5.0
Feb 20, 2020
Anonymous employee
Current employee, less than 1 year
Recommend
CEO approval
Business outlook
Pros
Strong financial position, diverse and evolving pipeline of new and partnered therapeutics, strong scientific leadership.
Cons
US site is in startup mode so things can be a bit hectic and structures are not fully in place to run at full speed.